IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools
 

Search About Journals, Conferences, and Book Series


CNS and Neurological Disorders - Drug Targets- Impact Score, Overall Ranking, h-index, SJR, Rating, Publisher, ISSN, and Other Important Metrics

Last Updated on May 27, 2022

Impact Score

2.71

h-Index

 90

Rank

 8900

SJR

 0.561

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics

Title CNS and Neurological Disorders - Drug Targets
Abbreviation CNS Neurol. Disord. - Drug Targets
Publication Type Journal
Subject Area, Categories, Scope Medicine (miscellaneous) (Q2); Neuroscience (miscellaneous) (Q3); Pharmacology (Q3)
h-index 90
Overall Rank/Ranking 8900
SCImago Journal Rank (SJR) 0.561
Impact Score 2.71
Publisher Bentham Science Publishers B.V.
Country United Arab Emirates
ISSN 18715273




About CNS and Neurological Disorders - Drug Targets


CNS and Neurological Disorders - Drug Targets is a journal covering the technologies/fields/categories related to Medicine (miscellaneous) (Q2); Neuroscience (miscellaneous) (Q3); Pharmacology (Q3). It is published by Bentham Science Publishers B.V.. The overall rank of CNS and Neurological Disorders - Drug Targets is 8900. According to SCImago Journal Rank (SJR), this journal is ranked 0.561. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 90. The best quartile for this journal is Q2.

The ISSN of CNS and Neurological Disorders - Drug Targets journal is 18715273. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. CNS and Neurological Disorders - Drug Targets is cited by a total of 722 articles during the last 3 years (Preceding 2021).




CNS and Neurological Disorders - Drug Targets Impact Score 2021-2022


The impact score (IS) 2021 of CNS and Neurological Disorders - Drug Targets is 2.71, which is computed in 2022 as per its definition. CNS and Neurological Disorders - Drug Targets IS is decreased by a factor of 1.22 and approximate percentage change is -31.04% when compared to preceding year 2020, which shows a falling trend. The impact score (IS), also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

CNS and Neurological Disorders - Drug Targets Impact Score 2022 Prediction


IS 2021 of CNS and Neurological Disorders - Drug Targets is 2.71. If the same downward trend persists, impact score may fall in 2022 as well.


Impact Score Trend


Year wise Impact Score (IS) of CNS and Neurological Disorders - Drug Targets. Based on Scopus data.


Year Impact Score (IS)
2022/2023 Coming Soon
2021 2.71
2020 3.93
2019 3.23
2018 2.33
2017 1.86
2016 2.46
2015 2.20
2014 2.45

CNS and Neurological Disorders - Drug Targets h-index


  Table Setting

CNS and Neurological Disorders - Drug Targets has an h-index of 90. It means 90 articles of this journal have more than 90 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




CNS and Neurological Disorders - Drug Targets ISSN


The ISSN of CNS and Neurological Disorders - Drug Targets is 18715273. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

CNS and Neurological Disorders - Drug Targets Rank and SCImago Journal Rank (SJR)


The overall rank of CNS and Neurological Disorders - Drug Targets is 8900. According to SCImago Journal Rank (SJR), this journal is ranked 0.561. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


CNS and Neurological Disorders - Drug Targets Publisher


Table Setting

CNS and Neurological Disorders - Drug Targets is published by Bentham Science Publishers B.V.. It's publishing house is located in United Arab Emirates. Coverage history of this journal is as following: 2006-2021. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of CNS and Neurological Disorders - Drug Targets is CNS Neurol. Disord. - Drug Targets. This abbreviation ('CNS Neurol. Disord. - Drug Targets') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in CNS and Neurological Disorders - Drug Targets


If your research field is/are related to Medicine (miscellaneous) (Q2); Neuroscience (miscellaneous) (Q3); Pharmacology (Q3), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Interdisciplinary Studies of Literature journal 22234 Knowledge Hub Publishing Company Limited (Hong Kong) 2 0.03
Anthropozoologica journal 15752 Museum National d'Histoire Naturelle 11 0.59
Soil and Environment journal 16081 Soil Science Society of Pakistan 20 1.23
Air and Space Law journal 17220 Kluwer Law International 3 0.44
Reviews on Advanced Materials Science journal 8012 Walter de Gruyter GmbH 61 5.06
Studies in Political Economy journal 11909 Taylor and Francis Ltd. 19 0.91
Brittonia journal 13022 Springer New York 28 0.70
Egyptian Pharmaceutical Journal(Egypt) journal 27002 Wolters Kluwer Medknow Publications 1 0.00
International Journal of Modern Education and Computer Science journal 12703 Modern Education and Computer Science Press 4 2.13
Confluencia journal 26564 University of Northern Colorado 4 0.07

Check complete list



Jasper


Year wise Impact Score (IS) of CNS and Neurological Disorders - Drug Targets

Impact Score Table

Year Impact Score (IS)
2022/2023 Coming Soon
2021 2.71
2020 3.93
2019 3.23
2018 2.33
2017 1.86
2016 2.46
2015 2.20
2014 2.45



Top Journals/Conferences in Medicine (miscellaneous)

MMWR Recommendations and Reports
Centers for Disease Control and Prevention (CDC) | United States

Nature Reviews Immunology
Nature Publishing Group | United Kingdom

New England Journal of Medicine
Massachussetts Medical Society | United States

Nature Medicine
Nature Publishing Group | United Kingdom

Physiological Reviews
American Physiological Society | United States

Lancet, The
Elsevier Ltd. | United Kingdom

Nature Reviews Disease Primers
Nature Publishing Group | United Kingdom

Journal of Clinical Oncology
American Society of Clinical Oncology | United States

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Annual Review of Pathology: Mechanisms of Disease
Annual Reviews Inc. | United States

See All

Top Journals/Conferences in Neuroscience (miscellaneous)

Nature Neuroscience
Nature Publishing Group | United Kingdom

Nature Reviews Neuroscience
Nature Publishing Group | United Kingdom

Annual Review of Neuroscience
Annual Reviews Inc. | United States

Neuron
Cell Press | United States

EMBO Journal
Wiley-Blackwell | Germany

eLife
eLife Sciences Publications | United Kingdom

Trends in Neurosciences
Elsevier Ltd. | United Kingdom

Current Opinion in Neurobiology
Elsevier Ltd. | United Kingdom

PLoS Biology
Public Library of Science | United States

Progress in Neurobiology
Elsevier Ltd. | United Kingdom

See All

Top Journals/Conferences in Pharmacology

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Pharmacological Reviews
American Society for Pharmacology and Experimental Therapeutics | United States

Journal for ImmunoTherapy of Cancer
BioMed Central Ltd. | United Kingdom

Annual Review of Pharmacology and Toxicology
Annual Reviews Inc. | United States

Drug Resistance Updates
Churchill Livingstone | United States

Trends in Pharmacological Sciences
Elsevier Ltd. | United Kingdom

Molecular Therapy
Cell Press | United States

Pharmacology and Therapeutics
Elsevier Inc. | United States

Cell Chemical Biology
Elsevier Inc. | United States

Alimentary Pharmacology and Therapeutics
Wiley-Blackwell Publishing Ltd | United Kingdom

See All